Ronald Labutti, DO
Adult Reconstructive Orthopaedic Surgery · Tulsa, OKNPI 1912980889
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (48.1%), travel and lodging and consulting fees — rather than concentrated in one kind of arrangement. 14 manufacturers reported payments, led by Medacta USA, Inc. at 41.9% of the total. Reporting peaked in 2023 at $2,072 and has fallen 71.1% since, to $600 in 2025.
Across 61 payments — averaging $98.55 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medacta USA, Inc.$3K
- Omnilife Science, Inc$2K
- Stryker$783
- Pacira Therapeutics, Inc.$225
- Davol Inc.$207
- Heraeus Medical, LLC.$196
- plus $441 from 8 others
What the payments were for
- Consulting fees$1,50025%
- Travel & lodging$1,62027%
- Food & beverage$2,89148%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medacta USA, Inc. | 17 | $2,518 |
| Omnilife Science, Inc | 4 | $1,641 |
| Stryker | 14 | $783 |
| Pacira Therapeutics, Inc. | 12 | $225 |
| Davol Inc. | 2 | $207 |
| Heraeus Medical, LLC. | 2 | $196 |
| Total Joint Orthopedics, Inc. | 1 | $127 |
| Heron Therapeutics, Inc. | 1 | $125 |
| Pacira Pharmaceuticals Incorporated | 2 | $39 |
| Polynovo North America LLC | 1 | $37 |
| Zimmer Biomet | 1 | $35 |
| Vertex | 2 | $33 |
| Johnson & Johnson | 1 | $26 |
| Ferring Pharmaceuticals Inc. | 1 | $19 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- AMISTEM$1,555
- GMK REVISION$236
- MAKO$233
- ARISTA AH FLEXITIP$189
- GMK SPHERE$147
- TRIATHLON$142
- Zilretta$125
- APONVIE$125
- Zynrelef$125
- PALACOS$123
How this compares
Too few adult reconstructive orthopaedic surgery providers in Oklahomato place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Lansoprazole | 127 | $1,756 |
| Cefadroxil | 139 | $1,592 |
| Oxycodone Hcl | 187 | $1,360 |
| Gabapentin | 172 | $1,160 |
| Tramadol Hcl | 201 | $939 |
| Diclofenac Sodium | 21 | $753 |
| Celecoxib | 27 | $635 |
| Methylprednisolone | 66 | $616 |
| Meloxicam | 146 | $425 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 69 | $119 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 16 | $79 |
| Clindamycin Hcl | 30 | $72 |
Paid to pharmacies, not to this prescriber.
Other adult reconstructive orthopaedic surgery in Tulsa
- Scott DunitzTulsa$186K
- Zackary BurrowTulsa$17K
- James SlaterTulsa$7K
- Christian LuessenhopTulsa$4K
- Jennifer PetersonTulsa$4K
- Justin ReidTulsa$4K
- Callen RagsdaleTulsa$1K
- Paul JacobOklahoma City$822K
- Corey PonderOklahoma City$291K
- Kyle McGivernOklahoma City$19K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.